Zoetis (ZTS) Tops Q4 EPS by 4c; Affirms FY16 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Zoetis' (ZTS) Simparica Should Gain Approval in March - Piper Jaffray
February 17, 2016 8:19 AM ESTDespite reducing Zoetis Inc. (NYSE: ZTS) price target by 9%, Piper Jaffray analyst, Kevin Ellich kept his Outperform rating and sees a near term catalyst as Simparica prepares for launch and Apoquel finds a second API source.
ZTS reported solid Q4 results highlighted by 6% operational growth which included 30% operational growth in U.S. companion animal product sales. Revenue beat Street estimates even with... More



